SlideShare a Scribd company logo
Muscle biopsy
Dr. Rahi Kiran. B
SR Neurology
 it is an essential element in the assessment of a
patient with suspected myopathy.
 The history 1860 when Duchenne first performed a
biopsy on a patient with symptoms of myopathy.
 time for biopsy, muscle to select, how many specimens
to obtain, and how to handle the specimen are
individualized
EPIMYSIUM
•Loose CT
•Blood vessels
PERIMYSIUM
•Septa
•Nerve branches
•Muscle spindles
•Fat
•Blood vessels
ENDOMYSIUM
•Muscle fibers
•Capillaries
•Small nerve fibers
General reasons:
 Weakness of uncertain cause-generalised, proximal
 floppy infant syndrome
 Muscle pain ,cramps, stiffness
 Persistently elevated muscle enzymes(CK)
 Specific reasons:
 Hereditary muscle disease in other family members - Carrier detection
 metabolic diseases such as storage disease
 Suspicion of steroid myopathy in treated myositis - Exclude drug induced
myopathy
 Conflicting clinical ,EMG or lab findings
 to distinguish between myopathy and neuropathy.
 Confirm/reinforce clinical diagnosis
 A normal biopsy in pt with high level of clinical suspicion of
a myopathy
 patient with known inflammatory myopathy who, after
improvement with steroid therapy, develops increasing
weakness.
 Biopsy findings can help distinguish between recurrence of
the inflammatory disorder and steroid myopathy.
1. Bleeding disorder
2.Most endocrine myopathies
3.Malignant hyperthermia
4.Poor nutrition
5.Prior Trauma
• Muscle with moderate disease, NOT severe
• Muscle belly, not from tendon
• Proximal myopathies/generalised systemic disease- Vastus
Lateralis
• Other sites-Biceps,gatronemius
• Avoid Deltoid,muscle that are site of EMG,injections/trauma
• Imaging used to select pathological muscle site in difficult cases.
Technique
1.Needle Biopsy
2.Open Biopsy- indicated for
disorders with patchy pathology
 Sample size: 0.5 cm diameter
1cm length
 Biopsy is processed:
1.Paraffin embedding
2.Histochemistry
3.For electron microscopy
4.For molecular biology
 The sample can be sent to the laboratory on saline gauze in a
sealed container on ice
 should not be immersed
 Ideally, immediately transported to the laboratory for
processing
 Fixed in paraformaldehyde, 3% glutaraldehyde, 10% formalin
Fresh Fixed
Muscle may be saved in saline moistened guage for several hrs
Keep the specimen cool
Do NOT immerse in saline ,fixative or other liquid
Glutaraldehyde, 4degree
EM ( 1mm x 0.5 cm)
Formalin
PARAFFIN (0.5x0.5cm)
inflammatory myopathies, vasculitis
Snap freeze
HISTOCHEMISTRY
(0.5x0.5cm) stains
Gel electrophoresis
western blot
 trauma to the muscle- disrupts architecture
 Electrocautery should not be used
sample coagulated by the application
of electrocautery
contraction band artifact
Perimysial
connective tissue
Endomysial
connective tissue
Note uniform sizes, polygonal shapes, and eccentric nuclei.
Normal muscle Adult Normal Muscle child
OIL RED O
H & E
Used to evaluate gen architecture of muscle and
variation in morphology of individual fibres
•Variation in fascicular architecture
•Variation in fiber size
•Necrosis and degeneration of muscle fibres
•Nuclear characteristics
•Type & distribution of inflammatory infiltrate
•Interstitial changes
Normal Internalisation of nuclei
• Myotonic dystrophy
• LGMD
• Myotendinous insertion
• Centronuclear myopathy
• Chronic neuropathies - jSMA
(60%)
 Fibrosis - all types of dystrophies and central core disease
•Limb girdle dystrophy
•Myotonic dystrophy
 Duchene muscular dystrophy
A hyalinised fiber is a fiber which has lost its cross
striations, has homogenous pale
Cytoplasm, Usually these fibers are rounded.
•Limb girdle muscular dystrophy
•Chronic neuropathies
 pale stained on H&E and infiltrated by phagocytes
(myophagocytosis) - DMD
Fiber necrosis Perifascicular necrosis
Pathologic features Disease
Small groups of necrotic
fibres
DMD
Perifascicular necrosis Dermatomyositis
Random fibre necrosis PM,IBM
Extensive,diffuse Rhabdomyolysis
Nuclear inclusions:
Oculopharyngeal dystrophy
Sarcoplasmic Inclusions:
Myofibrillar myopathy
Inclusion body myositis
Pathologic feature Disease
Perivascular, angiocentric DM, connective tissue
disease ,FSHD
Endomysial, around
fibres
PM, IBM,viral
Nodular Rheumatoid arthritis,
granuloma
Polymorphs with
eosinophils
PAN, drug reactions,
trichinosis, eosinophilic
fascitis
Type 1 fiber atophy Type 2 fiber atophy
•Myotonic dystrophy
•Nemaline myopathy
•Centronuclear myopathy
•Congenital fibre type
disproportion
Corticosteroid therapy
Myasthenia Gravis
Disuse Atrophy
Acute denervation
Paraneoplastic myopathy
Pattern of atrophy:
Grouped atrophy Chronic neurogenic disorders
Panfascicular ISMA(Infantile spinal muscular atrophy)
Perifascicular DM(Dermatomyositis)
Normal Atrophy
Denervation. Chronic denervation and reinnervation
Type 1 fiber
hypertrophy
Type 2 fiber
hypertrophy
Type 1&2 fiber
hypertrophy
ISMA
Normal Atheletes
Sprinters Limb girdle
dystrophy,IBM,myotonia
congenita,acromegaly
Normal Hypertrophy
Normal muscle-polygonal
Angular-neurogenic Rounded-myopathic
recognition of split fibers
is by a thin fibrous
septum, often
associated with a
nucleus that crosses
partway but not all the
way across the fiber.
modified Gomori’s trichrome (MGT) stain
 PH 9.4 - type 1 fibers - pale ,
type 2 fibers – dark,
viceversa at 4.6
 Type predominance – if > 55% (1, 2A,2B),
>80% - type 2
 Type 1 - normal in the gastrocnemius and deltoid muscles,
hallmark of congenital myopathies and many of the
early dystrophies.
 Type 2 - lateral head of the quadriceps muscle,
jSMA, MND
 Type 1 fiber atrophy - myotonic dystrophy type 1,
congenital myopathies and dystrophies
 Type 2 fiber atrophy - common , non specific –
chronic corticosteroid administration,
disuse,
RA, CTD,
Cancer,
mental retardation,
myasthenia gravis
Creatine kinase level: To rule out certain categories of myopathies
because different myopathies tend to generate a different levels of
elevation in CPK.
•High: (e.g. Dystrophinopathies) 200-300 times of normal.
•Intermediate: (e.g. Inflammatory myopathy) 20-30 times of normal.
•Low: (e.g. Neurogenic disorder) 2-5 times of normal.
 Lab. – Serum CK : elevated 20-100x normal
 EMG : myopathic features
 Muscle biopsy- Fiber necrosis & regeneration
Variation in fiber size,
internalisation of nuclei
proliferation of endomysial connective tissue.
Deficiency of dystrophin seen on
western blot analysis & IHC staining
DNA analysis : mutation of gene that encodes dystrophin
• Lab. – CK : elevated
-EMG : myopathic
- muscle biopsy : similar to DMD
: reduced amount or abnormality of
dystrophin( Dx)
- DNA analysis : deletions or duplications( Dx)
DMD
End stages-extensive
replacement
by adipose tissue and
fibrosis
• Lab. – Dx ; usually based on clinical findings
-CK : N or mildly elevated
-EMG : evidence of myotonia
-Biopsy : variation in fiber size,
increase in internal
nuclei(chains) ring,
selectively involves type – 1 fiber in 50%
Myotonic dystrophy
• Lab.– EMG: myopathic features
-CK : 2-3x N
-BIOPSY : presence of tubular filaments in muscle
cell nuclei,
mild dystrophic changes with nuclear
internalisation ,fiber atrophy,
Interstital fibrosis,
rimmed vacuoles in type 1 fibres
• Lab. – CK : N or elevated
- EMG: myopathic pattern
- BIOPSY: Atrophic muscle fibres in
clusters/groups in absence of necrosis,
- Moth eaten fibres and perivascular
inflammatory infiltrate
PM DM IBM
Muscle Biopsy “primary”
inflammation with
the CD8/MHC-I
complex & vacuoles
Endomysial
inflammation
Perifascicular,
perimysial, or
perivascular
infiltrates,
perifascicular atrophy
inflammatory
reactions
around blood vessels,
Primary inflammation
with CD8/MHC-I
complex; vacuolated
fibers with
b-amyloid deposits ,
Endomysial
inflammation
 Perifascicular atrophy
 Degeneration
 Inflammatory cells in the perimysium
surrounding a blood vessel
Congenital myopathies
1.Central core disease
2.Multicore disease
3.Nemaline(Rod) myopathy
4.Centronuclear myopathy
5.Congenital fibre type disproportion
• Lab. - CK: usually N or slightly elevated
- EMG : myopathic, myotonic discharges
- Biopsy : features specific to each type
•AD
•Biopsy- cytoplasmic cores
in type 1 Fibres – also in
HOCM
(NADH-TR stain)
•Cong non progressive myopathy(gen weakness,hypotonia)
•Biopsy –type 1 fiber predominance& minute core like
structures in majority of fibres
• AR/AD
• Aggregates of spindle shaped
particles(nemaline rods) occur
predominantly
 In type 1 fiber best seen MGT stain
Detected by MGT
•AD/AR/XL
•BIOPSY- Abundance of centrally located nuclei involving
majority of muscle fibres (mostly in type1 fibres)
•Atrophy of type 1
fibres, hypertrophy of
type 2 fibres
• Are the muscle fibres abnormal??
• Is the pathologic process-
neurogenic/myopathic??
• What is the distribution of pathology??
• Are there any diagnostic features??
 If abnormal??
 Size-small or large
 Shape-rounded or angular
 Type-grouping, fiber predominance
 Internal architecture-disordered/lost, vacuoles,Internal nuclei, inclusions
 Storage/acumulated material-glycogen, lipid, mitochondria
 NEUROGENIC/MYOGENIC
• Shape of muscle fibers –
• ROUND Myopathic
• ANGULAR Neurogenic
 ACUTE OR CHRONIC
 Acute:
 Myopathy-Muscle fiber regeneration
 Neuropathy-Small angular muscle fibers
 Chronic:
 Myopathy-increased endomysial connective tissue, muscle fiber atrophy &
hypertrophy
 Neuropathy-fiber type grouping ,pyknotic nuclear clumps
 UNIFORM- Dystrophy,
 REGIONAL - --
Neuropathy -Progressive denervation with reinnervation
Myopathy- Myopathic grouping, perifascicular atrophy
Inflammatory myopathies -Patchy fascicular changes,
focal denervation of Group of muscle fibers
 SCATTERED muscle fibers: Acute myopathy, Acute neuropathy
 In patients with suspected myopathy, needle EMG should be
performed on muscles on only one side of the body; a
subsequent muscle biopsy should be performed on the other
side.
 Bradley’s Neurology in Clinical Practice, 7th edition, 1915-19
 C. Sundaram and Megha S. Uppin (2012). Approach to the
Interpretation of Muscle Biopsy, Muscle Biopsy, Dr. Challa
Sundaram (Ed.), ISBN: 978-953-307-778-9
 Emedicine, medscape

More Related Content

What's hot

Recent advances in soft tissue tumors
Recent advances in soft tissue tumorsRecent advances in soft tissue tumors
Recent advances in soft tissue tumors
azfarneyaz
 
Interpretation of nerve biopsy
Interpretation of nerve biopsyInterpretation of nerve biopsy
Interpretation of nerve biopsy
Hajra Mehdi
 
Recent updates in cns tumors
Recent updates in cns tumorsRecent updates in cns tumors
Recent updates in cns tumors
dhanya89
 
Interpretation of renal biopsy
Interpretation of renal biopsyInterpretation of renal biopsy
Interpretation of renal biopsyBiswajeeta Saha
 
Introduction to Neuropathology
Introduction to NeuropathologyIntroduction to Neuropathology
Introduction to Neuropathology
Cassie Porebski
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
Dr. Munish Kumar
 
WHO BRAIN TUMOR CLASSIFICATION 5th EDITION
WHO BRAIN TUMOR CLASSIFICATION 5th EDITIONWHO BRAIN TUMOR CLASSIFICATION 5th EDITION
WHO BRAIN TUMOR CLASSIFICATION 5th EDITION
Kanhu Charan
 
Tensins 123
Tensins 123Tensins 123
Tensins 123
Spoorthy Gurajala
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhood
Sonic V S
 
Renal pediatric tumors
Renal pediatric tumorsRenal pediatric tumors
Renal pediatric tumors
MIMSR Medical college,Latur
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
Ipsita Panda
 
WHO CNS Tumor Classification 2021.pptx
WHO CNS Tumor Classification 2021.pptxWHO CNS Tumor Classification 2021.pptx
WHO CNS Tumor Classification 2021.pptx
Dr Sachin Biradar MS MCh Neurosurgery
 
Pathology of Demyelinating Disease
Pathology of Demyelinating DiseasePathology of Demyelinating Disease
Pathology of Demyelinating DiseaseML Cohen
 
Minimal residual disease
Minimal residual diseaseMinimal residual disease
Minimal residual disease
Appy Akshay Agarwal
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumours
ariva zhagan
 
2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx
RejoyceAnto
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reaction
Sindhuja Yella
 
CNS tumor classification.pptx
CNS tumor classification.pptxCNS tumor classification.pptx
CNS tumor classification.pptx
MohammadFaisal565026
 
CNS WHO 2021 tumor classification.pptx
CNS WHO 2021 tumor classification.pptxCNS WHO 2021 tumor classification.pptx
CNS WHO 2021 tumor classification.pptx
Dr. Rahul Jain
 
Small round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADASmall round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADA
Narmada Tiwari
 

What's hot (20)

Recent advances in soft tissue tumors
Recent advances in soft tissue tumorsRecent advances in soft tissue tumors
Recent advances in soft tissue tumors
 
Interpretation of nerve biopsy
Interpretation of nerve biopsyInterpretation of nerve biopsy
Interpretation of nerve biopsy
 
Recent updates in cns tumors
Recent updates in cns tumorsRecent updates in cns tumors
Recent updates in cns tumors
 
Interpretation of renal biopsy
Interpretation of renal biopsyInterpretation of renal biopsy
Interpretation of renal biopsy
 
Introduction to Neuropathology
Introduction to NeuropathologyIntroduction to Neuropathology
Introduction to Neuropathology
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
 
WHO BRAIN TUMOR CLASSIFICATION 5th EDITION
WHO BRAIN TUMOR CLASSIFICATION 5th EDITIONWHO BRAIN TUMOR CLASSIFICATION 5th EDITION
WHO BRAIN TUMOR CLASSIFICATION 5th EDITION
 
Tensins 123
Tensins 123Tensins 123
Tensins 123
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhood
 
Renal pediatric tumors
Renal pediatric tumorsRenal pediatric tumors
Renal pediatric tumors
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
 
WHO CNS Tumor Classification 2021.pptx
WHO CNS Tumor Classification 2021.pptxWHO CNS Tumor Classification 2021.pptx
WHO CNS Tumor Classification 2021.pptx
 
Pathology of Demyelinating Disease
Pathology of Demyelinating DiseasePathology of Demyelinating Disease
Pathology of Demyelinating Disease
 
Minimal residual disease
Minimal residual diseaseMinimal residual disease
Minimal residual disease
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumours
 
2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reaction
 
CNS tumor classification.pptx
CNS tumor classification.pptxCNS tumor classification.pptx
CNS tumor classification.pptx
 
CNS WHO 2021 tumor classification.pptx
CNS WHO 2021 tumor classification.pptxCNS WHO 2021 tumor classification.pptx
CNS WHO 2021 tumor classification.pptx
 
Small round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADASmall round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADA
 

Similar to Muscle bx

muscle biopsy site indications staining processing of muscle biopsy.pptx
muscle biopsy site indications staining processing of muscle biopsy.pptxmuscle biopsy site indications staining processing of muscle biopsy.pptx
muscle biopsy site indications staining processing of muscle biopsy.pptx
DrDivitasaxena1
 
Muscle biopsy –INDICATIONS, processing and morphology.pptx
Muscle biopsy –INDICATIONS, processing and morphology.pptxMuscle biopsy –INDICATIONS, processing and morphology.pptx
Muscle biopsy –INDICATIONS, processing and morphology.pptx
DrAbhisekkumar
 
68. myopathies
68. myopathies68. myopathies
68. myopathies
Amritpal Kaur
 
Approach to neuromuscular disorders
Approach to neuromuscular disordersApproach to neuromuscular disorders
Approach to neuromuscular disorders
Kasturba Medical College
 
approachtoneuromusculardisorders-180318071230.pptx
approachtoneuromusculardisorders-180318071230.pptxapproachtoneuromusculardisorders-180318071230.pptx
approachtoneuromusculardisorders-180318071230.pptx
jomns
 
muscle biopsy (3).ppt, diagnosis, types, biopsy
muscle biopsy (3).ppt, diagnosis, types, biopsymuscle biopsy (3).ppt, diagnosis, types, biopsy
muscle biopsy (3).ppt, diagnosis, types, biopsy
tejaswi71117
 
myopathy (1).pdf
myopathy (1).pdfmyopathy (1).pdf
myopathy (1).pdf
kireeti8
 
Myopathies - In detail (Classification and images)
Myopathies - In detail (Classification and images) Myopathies - In detail (Classification and images)
Myopathies - In detail (Classification and images)
Dr. Tushar Kariya
 
Myopathy
MyopathyMyopathy
Myopathy
Ankita Sain
 
Myopathies and myotonic dystrophies
Myopathies and myotonic dystrophiesMyopathies and myotonic dystrophies
Myopathies and myotonic dystrophies
gargitignath12
 
Muscle disorder and muscular dystrophy.pptx
Muscle disorder and muscular dystrophy.pptxMuscle disorder and muscular dystrophy.pptx
Muscle disorder and muscular dystrophy.pptx
srizananeupane
 
Neuromuscular Diseases medicine Seminar.pptx
Neuromuscular Diseases medicine Seminar.pptxNeuromuscular Diseases medicine Seminar.pptx
Neuromuscular Diseases medicine Seminar.pptx
thekeyman1
 
Myathenia Gravis
Myathenia GravisMyathenia Gravis
Myathenia Gravis
Amr Hassan
 
MUSCLE BIOPSY.pptx
MUSCLE BIOPSY.pptxMUSCLE BIOPSY.pptx
MUSCLE BIOPSY.pptx
aditisikarwar2
 
Muscular Dystrophy : Duchenne and Becker's
Muscular Dystrophy : Duchenne and Becker'sMuscular Dystrophy : Duchenne and Becker's
Muscular Dystrophy : Duchenne and Becker'sThe Medical Post
 
myopthies.pptx
myopthies.pptxmyopthies.pptx
myopthies.pptx
Mohamed Rizk Khodair
 
Myopathy
MyopathyMyopathy
Myopathy
BipulBorthakur
 
General pathology lecture 4 cellular adaptation
General pathology lecture 4 cellular adaptationGeneral pathology lecture 4 cellular adaptation
General pathology lecture 4 cellular adaptationviancksislove
 
approach to polyneuropathy
approach to polyneuropathyapproach to polyneuropathy
approach to polyneuropathy
Chetan Ganteppanavar
 
Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)
Caroline Karunya
 

Similar to Muscle bx (20)

muscle biopsy site indications staining processing of muscle biopsy.pptx
muscle biopsy site indications staining processing of muscle biopsy.pptxmuscle biopsy site indications staining processing of muscle biopsy.pptx
muscle biopsy site indications staining processing of muscle biopsy.pptx
 
Muscle biopsy –INDICATIONS, processing and morphology.pptx
Muscle biopsy –INDICATIONS, processing and morphology.pptxMuscle biopsy –INDICATIONS, processing and morphology.pptx
Muscle biopsy –INDICATIONS, processing and morphology.pptx
 
68. myopathies
68. myopathies68. myopathies
68. myopathies
 
Approach to neuromuscular disorders
Approach to neuromuscular disordersApproach to neuromuscular disorders
Approach to neuromuscular disorders
 
approachtoneuromusculardisorders-180318071230.pptx
approachtoneuromusculardisorders-180318071230.pptxapproachtoneuromusculardisorders-180318071230.pptx
approachtoneuromusculardisorders-180318071230.pptx
 
muscle biopsy (3).ppt, diagnosis, types, biopsy
muscle biopsy (3).ppt, diagnosis, types, biopsymuscle biopsy (3).ppt, diagnosis, types, biopsy
muscle biopsy (3).ppt, diagnosis, types, biopsy
 
myopathy (1).pdf
myopathy (1).pdfmyopathy (1).pdf
myopathy (1).pdf
 
Myopathies - In detail (Classification and images)
Myopathies - In detail (Classification and images) Myopathies - In detail (Classification and images)
Myopathies - In detail (Classification and images)
 
Myopathy
MyopathyMyopathy
Myopathy
 
Myopathies and myotonic dystrophies
Myopathies and myotonic dystrophiesMyopathies and myotonic dystrophies
Myopathies and myotonic dystrophies
 
Muscle disorder and muscular dystrophy.pptx
Muscle disorder and muscular dystrophy.pptxMuscle disorder and muscular dystrophy.pptx
Muscle disorder and muscular dystrophy.pptx
 
Neuromuscular Diseases medicine Seminar.pptx
Neuromuscular Diseases medicine Seminar.pptxNeuromuscular Diseases medicine Seminar.pptx
Neuromuscular Diseases medicine Seminar.pptx
 
Myathenia Gravis
Myathenia GravisMyathenia Gravis
Myathenia Gravis
 
MUSCLE BIOPSY.pptx
MUSCLE BIOPSY.pptxMUSCLE BIOPSY.pptx
MUSCLE BIOPSY.pptx
 
Muscular Dystrophy : Duchenne and Becker's
Muscular Dystrophy : Duchenne and Becker'sMuscular Dystrophy : Duchenne and Becker's
Muscular Dystrophy : Duchenne and Becker's
 
myopthies.pptx
myopthies.pptxmyopthies.pptx
myopthies.pptx
 
Myopathy
MyopathyMyopathy
Myopathy
 
General pathology lecture 4 cellular adaptation
General pathology lecture 4 cellular adaptationGeneral pathology lecture 4 cellular adaptation
General pathology lecture 4 cellular adaptation
 
approach to polyneuropathy
approach to polyneuropathyapproach to polyneuropathy
approach to polyneuropathy
 
Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)
 

More from NeurologyKota

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
NeurologyKota
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NeurologyKota
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptx
NeurologyKota
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
NeurologyKota
 
REMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptxREMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptx
NeurologyKota
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
NeurologyKota
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
NeurologyKota
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
NeurologyKota
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptx
NeurologyKota
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
NeurologyKota
 
CAROTID WEB.pptx
CAROTID WEB.pptxCAROTID WEB.pptx
CAROTID WEB.pptx
NeurologyKota
 
CNS IRIS.pptx
CNS IRIS.pptxCNS IRIS.pptx
CNS IRIS.pptx
NeurologyKota
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY
NeurologyKota
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptx
NeurologyKota
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptx
NeurologyKota
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
NeurologyKota
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NeurologyKota
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptx
NeurologyKota
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptx
NeurologyKota
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptx
NeurologyKota
 

More from NeurologyKota (20)

CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxCONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptx
 
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptxNEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
NEUROLOGICAL SCALES FOR ASSESSMENT OF CONSCIOUSNESS.pptx
 
LOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptxLOCALISATION OF LESION CAUSING COMA.pptx
LOCALISATION OF LESION CAUSING COMA.pptx
 
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptxTREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
TREADMILL For_BRAIN_Dr Bharat Bhushan sir.pptx
 
REMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptxREMOTE ROBOTIC.pptx
REMOTE ROBOTIC.pptx
 
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptxDUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
DUAL AND TRIPLE ANTITHROMBOTIC THERAPY FOR SECONDARY STROKE [Autosaved].pptx
 
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptxSMART WEARABLE DEVICES IN NEUROLOGY new.pptx
SMART WEARABLE DEVICES IN NEUROLOGY new.pptx
 
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptxASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
ASSESSMENT OF AUTONOMIC FUNCTION TEST.pptx
 
TRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptxTRANSCRANIAL DOPPLER (1).pptx
TRANSCRANIAL DOPPLER (1).pptx
 
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptxINTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
INTRACEREBRAL HEMORRHAGE IN YOUNG ADULTS.pptx
 
CAROTID WEB.pptx
CAROTID WEB.pptxCAROTID WEB.pptx
CAROTID WEB.pptx
 
CNS IRIS.pptx
CNS IRIS.pptxCNS IRIS.pptx
CNS IRIS.pptx
 
EPILEPTIC ENCEPHALOPATHY
 EPILEPTIC ENCEPHALOPATHY  EPILEPTIC ENCEPHALOPATHY
EPILEPTIC ENCEPHALOPATHY
 
Domain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptxDomain Assessment in Dementia.pptx
Domain Assessment in Dementia.pptx
 
Young Onset Dementia.pptx
Young Onset Dementia.pptxYoung Onset Dementia.pptx
Young Onset Dementia.pptx
 
ENCEPHALOPATHY
ENCEPHALOPATHY ENCEPHALOPATHY
ENCEPHALOPATHY
 
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
NEWER INSIGHT IN FUNCTIONAL NEUROLOGICAL DISORDER
 
Hyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptxHyperthermic syndrome in ICU and their management.pptx
Hyperthermic syndrome in ICU and their management.pptx
 
Entrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptxEntrapment Syndromes of Lower Limb.pptx
Entrapment Syndromes of Lower Limb.pptx
 
MOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptxMOG and IgG-4 related Neurological manifestation.pptx
MOG and IgG-4 related Neurological manifestation.pptx
 

Recently uploaded

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

Muscle bx

  • 1. Muscle biopsy Dr. Rahi Kiran. B SR Neurology
  • 2.  it is an essential element in the assessment of a patient with suspected myopathy.  The history 1860 when Duchenne first performed a biopsy on a patient with symptoms of myopathy.  time for biopsy, muscle to select, how many specimens to obtain, and how to handle the specimen are individualized
  • 3. EPIMYSIUM •Loose CT •Blood vessels PERIMYSIUM •Septa •Nerve branches •Muscle spindles •Fat •Blood vessels ENDOMYSIUM •Muscle fibers •Capillaries •Small nerve fibers
  • 4. General reasons:  Weakness of uncertain cause-generalised, proximal  floppy infant syndrome  Muscle pain ,cramps, stiffness  Persistently elevated muscle enzymes(CK)
  • 5.  Specific reasons:  Hereditary muscle disease in other family members - Carrier detection  metabolic diseases such as storage disease  Suspicion of steroid myopathy in treated myositis - Exclude drug induced myopathy  Conflicting clinical ,EMG or lab findings  to distinguish between myopathy and neuropathy.  Confirm/reinforce clinical diagnosis
  • 6.  A normal biopsy in pt with high level of clinical suspicion of a myopathy  patient with known inflammatory myopathy who, after improvement with steroid therapy, develops increasing weakness.  Biopsy findings can help distinguish between recurrence of the inflammatory disorder and steroid myopathy.
  • 7. 1. Bleeding disorder 2.Most endocrine myopathies 3.Malignant hyperthermia 4.Poor nutrition 5.Prior Trauma
  • 8. • Muscle with moderate disease, NOT severe • Muscle belly, not from tendon • Proximal myopathies/generalised systemic disease- Vastus Lateralis • Other sites-Biceps,gatronemius • Avoid Deltoid,muscle that are site of EMG,injections/trauma • Imaging used to select pathological muscle site in difficult cases.
  • 9. Technique 1.Needle Biopsy 2.Open Biopsy- indicated for disorders with patchy pathology
  • 10.  Sample size: 0.5 cm diameter 1cm length  Biopsy is processed: 1.Paraffin embedding 2.Histochemistry 3.For electron microscopy 4.For molecular biology
  • 11.  The sample can be sent to the laboratory on saline gauze in a sealed container on ice  should not be immersed  Ideally, immediately transported to the laboratory for processing  Fixed in paraformaldehyde, 3% glutaraldehyde, 10% formalin
  • 12. Fresh Fixed Muscle may be saved in saline moistened guage for several hrs Keep the specimen cool Do NOT immerse in saline ,fixative or other liquid Glutaraldehyde, 4degree EM ( 1mm x 0.5 cm) Formalin PARAFFIN (0.5x0.5cm) inflammatory myopathies, vasculitis Snap freeze HISTOCHEMISTRY (0.5x0.5cm) stains Gel electrophoresis western blot
  • 13.  trauma to the muscle- disrupts architecture  Electrocautery should not be used sample coagulated by the application of electrocautery contraction band artifact
  • 14.
  • 15. Perimysial connective tissue Endomysial connective tissue Note uniform sizes, polygonal shapes, and eccentric nuclei.
  • 16. Normal muscle Adult Normal Muscle child
  • 17.
  • 19. H & E Used to evaluate gen architecture of muscle and variation in morphology of individual fibres •Variation in fascicular architecture •Variation in fiber size •Necrosis and degeneration of muscle fibres •Nuclear characteristics •Type & distribution of inflammatory infiltrate •Interstitial changes
  • 21. • Myotonic dystrophy • LGMD • Myotendinous insertion • Centronuclear myopathy • Chronic neuropathies - jSMA (60%)
  • 22.  Fibrosis - all types of dystrophies and central core disease
  • 24.  Duchene muscular dystrophy A hyalinised fiber is a fiber which has lost its cross striations, has homogenous pale Cytoplasm, Usually these fibers are rounded.
  • 25. •Limb girdle muscular dystrophy •Chronic neuropathies
  • 26.  pale stained on H&E and infiltrated by phagocytes (myophagocytosis) - DMD Fiber necrosis Perifascicular necrosis
  • 27. Pathologic features Disease Small groups of necrotic fibres DMD Perifascicular necrosis Dermatomyositis Random fibre necrosis PM,IBM Extensive,diffuse Rhabdomyolysis
  • 28. Nuclear inclusions: Oculopharyngeal dystrophy Sarcoplasmic Inclusions: Myofibrillar myopathy Inclusion body myositis
  • 29. Pathologic feature Disease Perivascular, angiocentric DM, connective tissue disease ,FSHD Endomysial, around fibres PM, IBM,viral Nodular Rheumatoid arthritis, granuloma Polymorphs with eosinophils PAN, drug reactions, trichinosis, eosinophilic fascitis
  • 30.
  • 31. Type 1 fiber atophy Type 2 fiber atophy •Myotonic dystrophy •Nemaline myopathy •Centronuclear myopathy •Congenital fibre type disproportion Corticosteroid therapy Myasthenia Gravis Disuse Atrophy Acute denervation Paraneoplastic myopathy Pattern of atrophy: Grouped atrophy Chronic neurogenic disorders Panfascicular ISMA(Infantile spinal muscular atrophy) Perifascicular DM(Dermatomyositis)
  • 33. Denervation. Chronic denervation and reinnervation
  • 34. Type 1 fiber hypertrophy Type 2 fiber hypertrophy Type 1&2 fiber hypertrophy ISMA Normal Atheletes Sprinters Limb girdle dystrophy,IBM,myotonia congenita,acromegaly Normal Hypertrophy
  • 36. recognition of split fibers is by a thin fibrous septum, often associated with a nucleus that crosses partway but not all the way across the fiber.
  • 38.  PH 9.4 - type 1 fibers - pale , type 2 fibers – dark, viceversa at 4.6  Type predominance – if > 55% (1, 2A,2B), >80% - type 2
  • 39.
  • 40.  Type 1 - normal in the gastrocnemius and deltoid muscles, hallmark of congenital myopathies and many of the early dystrophies.  Type 2 - lateral head of the quadriceps muscle, jSMA, MND
  • 41.  Type 1 fiber atrophy - myotonic dystrophy type 1, congenital myopathies and dystrophies  Type 2 fiber atrophy - common , non specific – chronic corticosteroid administration, disuse, RA, CTD, Cancer, mental retardation, myasthenia gravis
  • 42. Creatine kinase level: To rule out certain categories of myopathies because different myopathies tend to generate a different levels of elevation in CPK. •High: (e.g. Dystrophinopathies) 200-300 times of normal. •Intermediate: (e.g. Inflammatory myopathy) 20-30 times of normal. •Low: (e.g. Neurogenic disorder) 2-5 times of normal.
  • 43.  Lab. – Serum CK : elevated 20-100x normal  EMG : myopathic features  Muscle biopsy- Fiber necrosis & regeneration Variation in fiber size, internalisation of nuclei proliferation of endomysial connective tissue. Deficiency of dystrophin seen on western blot analysis & IHC staining DNA analysis : mutation of gene that encodes dystrophin
  • 44. • Lab. – CK : elevated -EMG : myopathic - muscle biopsy : similar to DMD : reduced amount or abnormality of dystrophin( Dx) - DNA analysis : deletions or duplications( Dx)
  • 46. • Lab. – Dx ; usually based on clinical findings -CK : N or mildly elevated -EMG : evidence of myotonia -Biopsy : variation in fiber size, increase in internal nuclei(chains) ring, selectively involves type – 1 fiber in 50% Myotonic dystrophy
  • 47. • Lab.– EMG: myopathic features -CK : 2-3x N -BIOPSY : presence of tubular filaments in muscle cell nuclei, mild dystrophic changes with nuclear internalisation ,fiber atrophy, Interstital fibrosis, rimmed vacuoles in type 1 fibres
  • 48. • Lab. – CK : N or elevated - EMG: myopathic pattern - BIOPSY: Atrophic muscle fibres in clusters/groups in absence of necrosis, - Moth eaten fibres and perivascular inflammatory infiltrate
  • 49. PM DM IBM Muscle Biopsy “primary” inflammation with the CD8/MHC-I complex & vacuoles Endomysial inflammation Perifascicular, perimysial, or perivascular infiltrates, perifascicular atrophy inflammatory reactions around blood vessels, Primary inflammation with CD8/MHC-I complex; vacuolated fibers with b-amyloid deposits , Endomysial inflammation
  • 50.  Perifascicular atrophy  Degeneration  Inflammatory cells in the perimysium surrounding a blood vessel
  • 51. Congenital myopathies 1.Central core disease 2.Multicore disease 3.Nemaline(Rod) myopathy 4.Centronuclear myopathy 5.Congenital fibre type disproportion • Lab. - CK: usually N or slightly elevated - EMG : myopathic, myotonic discharges - Biopsy : features specific to each type
  • 52. •AD •Biopsy- cytoplasmic cores in type 1 Fibres – also in HOCM (NADH-TR stain)
  • 53. •Cong non progressive myopathy(gen weakness,hypotonia) •Biopsy –type 1 fiber predominance& minute core like structures in majority of fibres
  • 54. • AR/AD • Aggregates of spindle shaped particles(nemaline rods) occur predominantly  In type 1 fiber best seen MGT stain Detected by MGT
  • 55. •AD/AR/XL •BIOPSY- Abundance of centrally located nuclei involving majority of muscle fibres (mostly in type1 fibres)
  • 56. •Atrophy of type 1 fibres, hypertrophy of type 2 fibres
  • 57. • Are the muscle fibres abnormal?? • Is the pathologic process- neurogenic/myopathic?? • What is the distribution of pathology?? • Are there any diagnostic features??
  • 58.  If abnormal??  Size-small or large  Shape-rounded or angular  Type-grouping, fiber predominance  Internal architecture-disordered/lost, vacuoles,Internal nuclei, inclusions  Storage/acumulated material-glycogen, lipid, mitochondria  NEUROGENIC/MYOGENIC • Shape of muscle fibers – • ROUND Myopathic • ANGULAR Neurogenic
  • 59.  ACUTE OR CHRONIC  Acute:  Myopathy-Muscle fiber regeneration  Neuropathy-Small angular muscle fibers  Chronic:  Myopathy-increased endomysial connective tissue, muscle fiber atrophy & hypertrophy  Neuropathy-fiber type grouping ,pyknotic nuclear clumps
  • 60.  UNIFORM- Dystrophy,  REGIONAL - -- Neuropathy -Progressive denervation with reinnervation Myopathy- Myopathic grouping, perifascicular atrophy Inflammatory myopathies -Patchy fascicular changes, focal denervation of Group of muscle fibers  SCATTERED muscle fibers: Acute myopathy, Acute neuropathy
  • 61.  In patients with suspected myopathy, needle EMG should be performed on muscles on only one side of the body; a subsequent muscle biopsy should be performed on the other side.
  • 62.
  • 63.  Bradley’s Neurology in Clinical Practice, 7th edition, 1915-19  C. Sundaram and Megha S. Uppin (2012). Approach to the Interpretation of Muscle Biopsy, Muscle Biopsy, Dr. Challa Sundaram (Ed.), ISBN: 978-953-307-778-9  Emedicine, medscape